WHO ICTRP trial
Exploration de l'influence du polymorphisme *2 du gène codant pour le cytochrome…
EUCTR2007-004901-91-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-004901-91-FR |
|---|---|
| Public title | Exploration de l'influence du polymorphisme *2 du gène codant pour le cytochrome 2C19 sur la réponse au clopidogrel chez le jeune coronarien - CLOVIS 2 |
| Scientific title | Exploration de l'influence du polymorphisme *2 du gène codant pour le cytochrome 2C19 sur la réponse au clopidogrel chez le jeune coronarien - CLOVIS 2 |
| Primary sponsor | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France |
| Conditions | Les patients inclus dans cette étude seront issus de la cohorte AFIJI (Architecture de la FIbrine chez les Jeunes coronariens Ischémiques) MedDRA version: 8.1 Level: PT Classification code 10011099 Term: Coronary disease |
| Interventions | Trade Name: Plavix 75 mg Product Name: Plavix 75 mg Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Clopidogrel Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 75- |
| Registration date | Nov 29, 2007 |
| Secondary IDs | P070117 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: